<DOC>
	<DOCNO>NCT00905073</DOCNO>
	<brief_summary>The purpose study determine whether treatment low dose cyclosporin methotrexate inhibit development new onset diabetes mellitus</brief_summary>
	<brief_title>Low Dose Cyclosporin Methotrexate Therapy Diabetes</brief_title>
	<detailed_description>Objective : Although high dos cyclosporin ( cyclo ) inhibit development type 1 diabetes mellitus , usefulness limited toxicity . Since methotrexate ( mtx ) cyclo synergistically inhibit disease process , hypothesize low dose cyclo mtx therapy could safely induce remission . Research Design Methods : In open pilot study , insulin dose glycemic control compare child new onset Type 1 diabetes administer cyclo 7.5 mg/kg/day 6 week 4 mg/kg/day mtx 5 mg/kg/day one year control child . After 6 week , dos adjust maintain blood cyclo level 100-200 ng/ml .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Diagnosis Type1 diabetes mellitus obtain insulin therapy le 4 week Ketoacidosis Body weight 110 % ideal weight Condition immunosuppression contraindicate Abnormal liver renal function test</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>type 1 diabetes mellitus</keyword>
	<keyword>cyclosporin</keyword>
	<keyword>methotrexate</keyword>
	<keyword>renal function</keyword>
</DOC>